journal article·2019-09

Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia

Ling Chen, Yang Wu, Haoan Wu, Jianzhong Li, Jun Xie, Fengchao Zang, Ming Ma, Ning Gu, Yu Zhang

Acta Biomaterialia· Volume 96
Publisher page

Abstract

The combination of multi-targeting magnetic nanoprobes and multi-targeting strategies has potential to facilitate magnetic resonance imaging (MRI) and magnetic induction hyperthermia of the tumor. Although the thermo-agents based on magnetic iron oxide nanoparticles (MION) have been successfully used in the form of intratumoral injection in clinical cure of glioblastoma, the tumor-targeted thermotherapy by intravenous administration remains challenging. Herein, we constructed a c(RGDyK)- and d-glucosamine-grafted bispecific molecular nanoprobe (Fe3O4@RGD@GLU) with a magnetic iron oxide core of size 22.17 nm and a biocompatible shell of DSPE-PEG2000, which can specially target the tumor vessel and cancer cells. The selection of c(RGDyK) could make the nanoprobe enter the neovascularization endotheliocyte through αvβ3-mediated endocytosis, which drastically reduced the dependence on the enhanced permeability and retention (EPR) effect in tumor. This dual-ligand nanoprobe exhibited strong magnetic properties and favorable biocompatibility. In vitro studies confirmed the anti-phagocytosis ability against macrophages and the specific targeting capability of Fe3O4@RGD@GLU. Then, the imaging effect and anti-tumor efficacy were compared using different targeting strategies with untargeted nanoprobes, dual-targeted nanoprobes, and magnetic targeting combined with dual-targeted nanoprobes. Moreover, the combination strategy of magnetic targeting and active targeting promoted the penetration depth of nanoprobes in addition to the increased accumulation in tumor tissue. Thus, the dual-targeted magnetic nanoprobe together with the combined targeting strategy could be a promising method in tumor imaging and hyperthermia through in vivo delivery of theranostic agents. STATEMENT OF SIGNIFICANCE: Magnetic induction hyperthermia based on iron oxide nanoparticles has been used in clinic for adjuvant treatment of recurrent glioblastoma. Nonetheless, this application is limited to intratumoral injection, and tumor-targeted hyperthermia by intravenous injection remains challenging. In this study, we developed a multi-targeted strategy by combining magnetic targeting with active targeting of dual-ligand magnetic nanoprobes. This combination mode acquired optimum contrast imaging effect through MRI and tumor-suppressive effect through hyperthermia under an alternating current magnetic field. The design of the nanoprobe was suitable for targeting most tumor lesions, which enabled it to be an effective theranostic agent with extensive uses. This study showed significant enhancement of the penetration depth and accumulation of nanoprobes in the tumor tissue for efficient imaging and hyperthermia.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Microfluidic and Bio-sensing Technologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (56)

Show source-provided references
1. A preliminary study on the influence of liver cirrhosis on the liver with Feridex-enchanced MRI
2. Ferumoxytol for the treatment of iron deficiency10.1586/ehm.11.31 ↗
3. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron10.1002/ajh.23582 ↗
4. Ferumoxytol for treating iron deficiency anemia in CKD10.1681/ASN.2007101156 ↗
5. Maximizing specific loss power for magnetic hyperthermia by hard-soft mixed ferrites
6. Magnetic nanoparticles: biomedical applications and challenges10.1039/c0jm00994f ↗
7. Magnetic particle hyperthermia-a promising tumour therapy?10.1088/0957-4484/25/45/452001 ↗
8. Hyperthermia-induced drug targeting10.1517/17425247.2013.758631 ↗
9. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery10.1186/s13058-015-0576-1 ↗
10. High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area10.1007/s11095-014-1417-0 ↗
11. Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma10.7150/thno.18927 ↗
12. Heat-generating iron oxide nanocubes: subtle “destructurators” of the tumoral microenvironment10.1021/nn405356r ↗
13. Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy’s history, efficacy, and application in humans
14. Using PEGylated magnetic nanoparticles to describe the EPR effect in tumor for predicting therapeutic efficacy of micelle drugs10.1039/C7NR08319J ↗
15. Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
16. Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer10.2147/IJN.S139011 ↗
17. Spatiotemporal targeting of a dual-ligand nanoparticle to cancer metastasis10.1021/acsnano.5b01552 ↗
18. Bispecific antibody conjugated manganese-based magnetic engineered iron oxide for imaging of HER2/neu- and EGFR-expressing tumors10.7150/thno.13069 ↗
19. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT10.1016/j.ijpharm.2013.06.048 ↗
20. cRGD/TAT dual-ligand reversibly cross-linked micelles loaded with docetaxel penetrate deeply into tumor tissue and show high antitumor efficacy in vivo10.1021/acsami.7b12439 ↗
21. Dual targeting hyaluronic acid - RGD mesoporous silica coated gold nanorods for chemo-photothermal cancer therapy10.1016/j.msec.2017.08.002 ↗
22. Facile construction of dual-targeting delivery system by using lipid capped polymer nanoparticles for anti-glioma therapy10.1039/C7RA12376K ↗
23. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide10.1080/10717544.2018.1425777 ↗
24. Glioma targeted delivery strategy of doxorubicin-loaded liposomes by dual-ligand modification10.1080/09205063.2017.1348739 ↗
25. Dual systemic tumor targeting with ligand-directed phage and Grp78 promoter induces tumor regression10.1158/1535-7163.MCT-12-0587 ↗
26. Magnetic nanoliposomes as in situ microbubble bombers for multimodality image-guided cancer theranostics10.1021/acsnano.6b06815 ↗
27. Magnetic forces enable controlled drug delivery by disrupting endothelial cell-cell junctions10.1038/ncomms15594 ↗
28. Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer10.1016/j.jconrel.2018.04.052 ↗
29. Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions10.1038/nnano.2016.137 ↗
30. Magnetic therapeutic delivery using navigable agents10.4155/tde.13.147 ↗
31. Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy10.1016/j.jconrel.2014.07.059 ↗
32. Improving sensitivity of magnetic resonance imaging by using a dual-targeted magnetic iron oxide nanoprobe10.1016/j.colsurfb.2017.10.059 ↗
33. Shape evolution of “multibranched” Mn–Zn ferrite nanostructures with high performance: a transformation of nanocrystals into nanoclusters10.1021/cm402036d ↗
34. Injectable magnetic supramolecular hydrogel with magnetocaloric liquid-conformal property prevents post-operative recurrence in a breast cancer model10.1016/j.actbio.2018.04.052 ↗
35. Influence of morphology and surface exchange reaction on magnetic properties of monodisperse magnetite nanoparticles10.1016/j.colsurfa.2012.05.039 ↗
36. Multi-modal Mn-Zn ferrite nanocrystals for magnetically-induced cancer targeted hyperthermia: a comparison of passive and active targeting effects10.1039/C6NR03916B ↗
37. Injectable thermosensitive magnetic nanoemulsion hydrogel for multimodal-imaging-guided accurate thermoablative cancer therapy10.1039/C7NR02858J ↗
38. Precise study on size-dependent properties of magnetic iron oxide nanoparticles for in vivo
39. Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment10.7150/thno.5860 ↗
40. Water-dispersible ferrimagnetic iron oxide nanocubes with extremely high r₂ relaxivity for highly sensitive in vivo MRI of tumors10.1021/nl3010308 ↗
41. Water dispersible superparamagnetic cobalt iron oxide nanoparticles for magnetic fluid hyperthermia10.1016/j.jmmm.2016.06.057 ↗
42. Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours10.1007/PL00008466 ↗
43. Glucosamine-conjugated nanoparticles for the separation of insulin-secreting beta cells10.1002/adhm.201200479 ↗
44. MRI of high-glucose metabolism tumors: a study in cells and mice with 2-DG-modified superparamagnetic iron oxide nanoparticles10.1007/s11307-015-0874-0 ↗
45. Inhibiting notch activity in breast cancer stem cells by glucose functionalized nanoparticles carrying γ-secretase inhibitors10.1038/mt.2016.42 ↗
46. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner10.1158/0008-5472.CAN-06-1668 ↗
47. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis
48. Effective PEGylation of iron oxide nanoparticles for high performance in vivo cancer imaging10.1002/adfm.201001658 ↗
49. Lymphatic metastasis in the absence of functional intratumor lymphatics10.1126/science.1071420 ↗
50. A dual ligand targeted nanoprobe with high MRI sensitivity for diagnosis of breast cancer10.1007/s10118-014-1399-8 ↗
51. Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment10.1021/nn2048137 ↗
52. Magnetic particle hyperthermia—biophysical limitations of a visionary tumour therapy10.1016/j.jmmm.2006.10.1156 ↗
53. Analysis of nanoparticle delivery to tumours10.1038/natrevmats.2016.14 ↗
54. Intravenous magnetic nanoparticle cancer hyperthermia
55. Magnetic particle imaging guided heating in vivo using gradient fields for arbitrary localization of magnetic hyperthermia therapy10.1021/acsnano.8b00893 ↗
56. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model10.1158/0008-5472.CAN-06-4102 ↗